Drägerwerk AG & Co. KGaA
DGWPF
Other OTC83.00
USD
- -
- -
ISIN
DE0005550602
Return %
Stock
S&P500
1Y
45.61
26.53
3Y
109.75
76.60
5Y
4.64
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Stefan A. Drager
- Full Time Employees
- 15,444
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Moislinger Allee 53-55 Lübeck Germany 23558
- IPO Date
- Mar 7, 2012
- Website
- draeger.com
- Similar Companies
- Business
- Drägerwerk AG & Co. KGaA develops, manufactures and markets medical and safety technology products and systems that protect, support and save lives in hospitals, fire departments, emergency services, mining and industry; its medical division offers anaesthesia workstations, ventilators for intensive and emergency care including the Evita series, patient monitoring systems, neonatal incubators and thermoregulation equipment such as Babyroo and Babylog, phototherapy lights and bilirubinometers, surgical and examination lights, hospital consumables and accessories, medical gas pipeline systems, ceiling pendants and infrastructure design services; its safety division provides respiratory protection equipment including powered air-purifying respirators like Dräger X-plore 8700 and self-contained breathing apparatus such as Dräger BG ProAir, stationary and portable gas detection systems including Dräger X-am 8000 multi-gas detectors and colorimetric detector tubes, professional diving technology, alcohol and drug testing devices, thermal imaging cameras like Dräger UCF FireCore, hazmat suits, head and eye protection, firefighting equipment, fire training facilities and integrated hazard management solutions. Founded in 1889 and headquartered in Lübeck, Germany, the family-owned company operates sales and service subsidiaries in approximately 50 countries, with products sold in over 190 countries worldwide, and maintains 18 to 20 development and production sites including facilities in Germany, the United Kingdom, the Czech Republic, the United States, Sweden, South Africa, China and Brazil; it serves target markets in healthcare for acute point-of-care including perioperative, intensive and emergency medicine, and industrial sectors such as oil and gas, chemicals, mining, resource extraction and fire rescue services. In 2024, Dräger generated net sales of EUR 3.4 billion with the medical division contributing EUR 1.9 billion and safety division EUR 1.47 billion, invested EUR 331.1 million in research and development including 24 new products, reported strong order intake growth in the first nine months of 2025 surpassing prior-year figures amid robust safety division performance and improved gross margins from favorable product mix and capacity utilization, and sold its measurement technology unit Dräger MSI GmbH to Rems-Messtechnik GmbH & Co. KG while ceasing safety technology operations in Russia following geopolitical sanctions.
Drägerwerk AG & Co. KGaA (DGWPF) Q4 2025 Earnings Call Transcript
Drägerwerk AG & Co. KGaA (DGWPF) Q3 2025 Earnings Call Transcript
Drägerwerk AG & Co. KGaA (DGWPF) Q2 2025 Earnings Call Transcript
Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript